HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 2 of 2
DTX401 Gene Therapy in Glycogen Storage Disease (GSD) Type Ia
Our team at the Congenital Hyperinsulinism Center at CHOP is working on a research study to determine whether an experimental gene therapy product, DTX401, is safe and effective in people with glycogen storage disease type Ia (GSDIa)
Related PI: Diva D. De León-Crutchlow, MD, MSCE
Related Conditions: AAV Vectors, Hyperinsulinism, Adeno-associated Viral Vectors, Viral Vectors, Hypoglycemia, Clinical Trials, Rare Disorder Natural History Studies and Clinical Trials, Endocrinology Disorders, Gene Therapy Research, Gene Transfer Therapy, Rare Disease, Diabetes and other Metabolic Diseases, Pediatric Endocrinology, Rare Genetic Disorders, Pediatric Genetic Disease, Genetic Disease, Genetic Mutations, Gene Therapy, Genetic Disorders, Metabolic Disease, Metabolic Disorders
UX053 in GSD III
Our team at the Congenital Hyperinsulinism Center at CHOP is working on a clinical drug trial that involves giving you a study drug called UX033.
Related PI: Diva D. De León-Crutchlow, MD, MSCE
Related Conditions: Metabolic Disease, Metabolic Disorders, Endocrinology Disorders, Hyperinsulinism, Hypoglycemia, Clinical Research, Clinical Trials, Rare Disorder Natural History Studies and Clinical Trials, Rare Genetic Disorders, Diabetes and other Metabolic Diseases, Rare Disease, Genetic Disease, Genetic Disorders